Suppression of RIP1 activity via S415 dephosphorylation ameliorates obesity-related hepatic insulin resistance.

Yanping WangJie XiongYanmei YuanChao PengPing WuYibing WangJunxi LuYue YinJunting XuSuzhen ChenWeiping Jia

Published in: Obesity (Silver Spring, Md.) (2022)

These findings highlight the diabetogenic role of RIP1 S415 and propose RIP1 as a promising therapeutic target for type 2 diabetes.

Keyphrases